Diabetes, Vol 46, Issue 4 726-730, Copyright © 1997 by American Diabetes Association

ARTICLES

Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation

T Hansen, H Eiberg, M Rouard, M Vaxillaire, AM Moller, SK Rasmussen, M Fridberg, SA Urhammer, JJ Holst, K Almind, SM Echwald, L Hansen, GI Bell and O Pedersen
Steno Diabetes Center and Hagendorn Research Institute, Copenhagen, Denmark.

One form of maturity-onset diabetes of the young (MODY3) results from mutations in the hepatocyte nuclear factor (HNF)-1alpha gene, located on chromosome 12q24.2. The primary objective of the present study was to search for genetic variation in the HNF-1alpha gene in nine nonrelated Danish Caucasian subjects with MODY. Direct sequencing of the coding region and intron-exon boundaries of the HNF-1alpha gene revealed 2 novel and 1 previously reported missense mutations and 2 novel frameshift mutations in five of nine MODY subjects. These five mutations were found in neither 84 NIDDM patients nor 84 control subjects. One glucose-tolerant lean male with a P447L missense mutation, which in his relatives caused MODY, underwent an oral glucose tolerance test (OGTT), a tolbutamide modified frequently sampled intravenous glucose tolerance test, and a glucagon test to examine for a possible early beta-cell abnormality. He had a low insulin secretion rate during an OGTT, but a twofold increase in pancreatic beta-cell response after intravenous glucose and a 2.5- to 4-fold increase in beta-cell response after either intravenous tolbutamide or intravenous glucagon loads. In conclusion, 1) mutations in the HNF-1alpha gene are common in Danish Caucasian MODY patients, and 2) early stages in the pathogenesis of MODY3 caused by the P447L mutation may be characterized by a hyperexcitability of beta-cells to intravenous secretagogues.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Tuomi, E. H. Honkanen, B. Isomaa, L. Sarelin, and L. C. Groop Improved Prandial Glucose Control With Lower Risk of Hypoglycemia With Nateglinide Than With Glibenclamide in Patients With Maturity-Onset Diabetes of the Young Type 3 Diabetes Care, February 1, 2006; 29(2): 189 - 194. [Abstract] [Full Text] [PDF]

				A. Johansen, J. Ek, H. B. Mortensen, O. Pedersen, and T. Hansen Half of Clinically Defined Maturity-Onset Diabetes of the Young Patients in Denmark Do Not Have Mutations in HNF4A, GCK, and TCF1 J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4607 - 4614. [Abstract] [Full Text] [PDF]

				E. R. Pearson, M. K. Badman, C. R. Lockwood, P. M. Clark, S. Ellard, C. Bingham, and A. T. Hattersley Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1{alpha} and -1{beta} Mutations Diabetes Care, May 1, 2004; 27(5): 1102 - 1107. [Abstract] [Full Text] [PDF]

				T. Vilsboll, F. K. Knop, T. Krarup, A. Johansen, S. Madsbad, S. Larsen, T. Hansen, O. Pedersen, and J. J. Holst The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide--Regardless of Etiology and Phenotype J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4897 - 4903. [Abstract] [Full Text] [PDF]

				P. Boileau, C. Wolfrum, D. Q. Shih, T.-A. Yang, A. W. Wolkoff, and M. Stoffel Decreased Glibenclamide Uptake in Hepatocytes of Hepatocyte Nuclear Factor-1{alpha}-Deficient Mice: A Mechanism for Hypersensitivity to Sulfonylurea Therapy in Patients With Maturity-Onset Diabetes of the Young, Type 3 (MODY3) Diabetes, December 1, 2002; 51(90003): S343 - 348. [Abstract] [Full Text] [PDF]

				J. Ferrer A Genetic Switch in Pancreatic {beta}-Cells: Implications for Differentiation and Haploinsufficiency Diabetes, August 1, 2002; 51(8): 2355 - 2362. [Abstract] [Full Text] [PDF]

				H. Wobser, H. Du{beta}mann, D. Kogel, H. Wang, C. Reimertz, C. B. Wollheim, M. M. Byrne, and J. H. M. Prehn Dominant-negative Suppression of HNF-1alpha Results in Mitochondrial Dysfunction, INS-1 Cell Apoptosis, and Increased Sensitivity to Ceramide-, but Not to High Glucose-induced Cell Death J. Biol. Chem., February 15, 2002; 277(8): 6413 - 6421. [Abstract] [Full Text] [PDF]

				K. C. Chiu, L.-M. Chuang, J. M. Ryu, G. P. Tsai, and M. F. Saad The I27L Amino Acid Polymorphism of Hepatic Nuclear Factor-1{alpha} Is Associated with Insulin Resistance J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2178 - 2183. [Abstract] [Full Text]

				Q.-X. Hua, M. Zhao, N. Narayana, S. H. Nakagawa, W. Jia, and M. A. Weiss Diabetes-associated mutations in a beta -cell transcription factor destabilize an antiparallel "mini-zipper" in a dimerization interface PNAS, February 29, 2000; 97(5): 1999 - 2004. [Abstract] [Full Text] [PDF]

				R. A. Hegele, H. Cao, S. B. Harris, A. J. G. Hanley, B. Zinman, and P. W. Connelly The Private Hepatocyte Nuclear Factor-1{alpha} G319S Variant Is Associated With Plasma Lipoprotein Variation in Canadian Oji-Cree Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 217 - 222. [Abstract] [Full Text] [PDF]

				M. Vaxillaire, A. Abderrahmani, P. Boutin, B. Bailleul, P. Froguel, M. Yaniv, and M. Pontoglio Anatomy of a Homeoprotein Revealed by the Analysis of Human MODY3 Mutations J. Biol. Chem., December 10, 1999; 274(50): 35639 - 35646. [Abstract] [Full Text] [PDF]

				R. A. Hegele, H. Cao, S. B. Harris, A. J. G. Hanley, and B. Zinman The Hepatic Nuclear Factor-1{alpha} G319S Variant Is Associated with Early-Onset Type 2 Diabetes in Canadian Oji-Cree J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1077 - 1082. [Abstract] [Full Text]

				A. M. Møller, L. T. Dalgaard, L. Ambye, L. Hansen, O. Schmitz, T. Hansen, and O. Pedersen A Novel Phe75fsdelT Mutation in the Hepatocyte Nuclear Factor-4{alpha} Gene in a Danish Pedigree with Maturity-Onset Diabetes of the Young J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 367 - 369. [Abstract] [Full Text]

				S. A. Urhammer, T. Hansen, C. T. Ekstrøm, H. Eiberg, and O. Pedersen The Ala/Val98 Polymorphism of the Hepatocyte Nuclear Factor-1{alpha} Gene Contributes to the Interindividual Variation in Serum C-Peptide Response during an Oral Glucose Tolerance Test: Evidence from Studies of 231 Glucose-Tolerant First Degree Relatives of Type 2 Diabetic Probands J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4506 - 4509. [Abstract] [Full Text]

				S. C. Elbein, K. Teng, P. Yount, and E. Scroggin Linkage and Molecular Scanning Analyses of MODY3/Hepatocyte Nuclear Factor-1{alpha} Gene in Typical Familial Type 2 Diabetes: Evidence for Novel Mutations in Exons 8 and 10 J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2059 - 2065. [Abstract] [Full Text]

				T. Mandrup-Poulsen Recent advances: Diabetes BMJ, April 18, 1998; 316(7139): 1221 - 1225. [Full Text]